- Home
- THQ vs MLAB Comparison
THQ vs MLAB Comparison
Compare THQ & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THQ
- MLAB
- Stock Information
- Founded
- THQ 2014
- MLAB 1982
- Country
- THQ United States
- MLAB United States
- Employees
- THQ N/A
- MLAB N/A
- Industry
- THQ Finance Companies
- MLAB Industrial Machinery/Components
- Sector
- THQ Finance
- MLAB Industrials
- Exchange
- THQ Nasdaq
- MLAB Nasdaq
- Market Cap
- THQ 845.7M
- MLAB 680.0M
- IPO Year
- THQ N/A
- MLAB N/A
- Fundamental
- Price
- THQ $20.44
- MLAB $119.57
- Analyst Decision
- THQ
- MLAB Hold
- Analyst Count
- THQ 0
- MLAB 2
- Target Price
- THQ N/A
- MLAB $140.00
- AVG Volume (30 Days)
- THQ 158.9K
- MLAB 45.3K
- Earning Date
- THQ 01-01-0001
- MLAB 02-04-2025
- Dividend Yield
- THQ 7.53%
- MLAB 0.54%
- EPS Growth
- THQ N/A
- MLAB N/A
- EPS
- THQ N/A
- MLAB N/A
- Revenue
- THQ N/A
- MLAB $237,747,000.00
- Revenue This Year
- THQ N/A
- MLAB $13.48
- Revenue Next Year
- THQ N/A
- MLAB $4.74
- P/E Ratio
- THQ N/A
- MLAB N/A
- Revenue Growth
- THQ N/A
- MLAB 11.68
- 52 Week Low
- THQ $15.29
- MLAB $83.68
- 52 Week High
- THQ $20.38
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- THQ 46.91
- MLAB 37.05
- Support Level
- THQ $20.20
- MLAB $121.89
- Resistance Level
- THQ $21.07
- MLAB $130.12
- Average True Range (ATR)
- THQ 0.33
- MLAB 4.45
- MACD
- THQ -0.05
- MLAB -0.25
- Stochastic Oscillator
- THQ 31.87
- MLAB 18.72
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.